Ginsenoside Rh4

Basic Information

View in Editor

CAS Number

174721-08-5

Molecular Formula

C36H60O8

Molecular Weight

620.86 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Polymers and Plastics Thermoplastics Polyolefins

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

Powder

Solubility

Methanol; Acetone; Ethyl Acetate

SMILES

View in Editor

OC[C@H]1O[C@@H](O[C@H]2C[C@]3(C)[C@@H]([C@@]4([C@@H]2C(C)(C)[C@@H](O)CC4)C)C[C@H]([C@H]2[C@@]3(C)CC[C@@H]2/C(=C/CC=C(C)C)/C)O)[C@@H]([C@H]([C@@H]1O)O)O

InChI

InChI=1S/C36H60O8/c1-19(2)10-9-11-20(3)21-12-15-35(7)27(21)22(38)16-25-34(6)14-13-26(39)33(4,5)31(34)23(17-36(25,35)8)43-32-30(42)29(41)28(40)24(18-37)44-32/h10-11,21-32,37-42H,9,12-18H2,1-8H3/b20-11+/t21-,22-,23+,24-,25-,26+,27+,28-,29+,30-,31+,32-,34-,35-,36-/m1/s1

InChIKey

OZTXYFOXQFKYRP-TXRYYSRHSA-N

LogP

4.100800000000007

Topological Polar Surface Area

139.84 Å²

Hydrogen Bond Donor/Acceptor

6 / 8

Complexity

1120

Safety Information

View Safety Information

Storage Conditions

-20℃

Synonyms & References

English

Ginsenoside RH4
Ginsenoside Rh(4)
beta-D-glucopyranoside, (3beta,6alpha,12beta,20E)-3,12-dihydroxydammara-20(22),24-dien-6-yl
(3beta,6alpha,12beta,20E)-3,12-Dihydroxydammara-20(22),24-dien-6-yl-beta-D-glucopyranoside
(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethyl-17-

MDL Number

MFCD22125012

FAQ

What regulatory guidelines apply to Ginsenoside Rh4 (CAS: 174721-08-5)?

Ginsenoside Rh4 (CAS: 174721-08-5) falls under the scrutiny of global regulatory bodies such as REACH (Registration, Evaluation, Authorisation, and Restriction of Chemicals) in the EU, which mandates the registration of substances above 1 tonne per year. In the US, FDA (Food and Drug Administration) and EPA (Environmental Protection Agency) have specific safety and environmental requirements for substances used in dietary supplements and consumer products. Additionally, the chemical should comply with local and regional safety standards and guidelines.

Are there alternatives to Ginsenoside Rh4 in synthesis?

In the synthesis of Ginsenoside Rh4, alternative precursors and reagents can be used to synthesize similar compounds. For instance, ginsenoside Rg3 can serve as a precursor, and alternative reagents like sodium borohydride or lithium aluminum hydride can be used as reducing agents. These alternatives offer flexibility in the synthesis process while maintaining the structural integrity of the final product.

What is the market or research trend for Ginsenoside Rh4 (CAS: 174721-08-5)?

The market for Ginsenoside Rh4 is growing due to its potential health benefits, particularly in the areas of cancer treatment and immunomodulation. Research trends are focused on understanding its mechanism of action and developing new formulations. Market trends show increasing demand in dietary supplements and pharmaceuticals, with ongoing studies exploring its efficacy and safety in clinical trials.

How should waste containing Ginsenoside Rh4 (CAS: 174721-08-5) be handled?

Waste containing Ginsenoside Rh4 should be collected and disposed of in compliance with local environmental regulations. Proper incineration is recommended for disposal, and professional waste disposal services are advised to ensure environmental safety. Precautions include ensuring the waste is sealed and labeled appropriately to prevent leakage or contamination. Additionally, the waste should be treated to minimize the risk of environmental impact during disposal.